Gajendra P S Raghava Selected Research

Gajendra P S Raghava Research Topics

Disease

31	Neoplasms (Cancer) 02/2022 - 07/2009
5	COVID-19 02/2022 - 12/2020
4	Carcinogenesis 02/2022 - 10/2019
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2012
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 04/2008
2	Infections 01/2022 - 12/2013
2	Papillary Thyroid Cancer 01/2021 - 01/2020
2	Hypersensitivity (Allergy) 01/2021 - 05/2005
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2014
2	Tuberculosis (Tuberculoses) 01/2018 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014 - 02/2014
1	Hyperplasia 02/2022
1	Respiratory Hypersensitivity 02/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Central Nervous System Diseases (CNS Diseases) 11/2021
1	Cytokine Release Syndrome 10/2021
1	Acute-Phase Reaction 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Disease Progression 04/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Kidney Neoplasms (Kidney Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 03/2014
1	Parasitic Diseases (Parasitic Disease) 01/2014
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Osteoporosis 07/2009

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2013
12	Peptides (Polypeptides)IBA 02/2022 - 05/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
10	Pharmaceutical PreparationsIBA 12/2020 - 01/2013
7	VaccinesIBA 01/2021 - 05/2005
3	EpitopesIBA 01/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
3	Pattern Recognition ReceptorsIBA 01/2020 - 04/2008
3	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2019
2	CytokinesIBA 10/2021 - 01/2021
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019 - 04/2008
2	AntigensIBA 01/2016 - 01/2010
2	Amino Acids FDA Link 01/2013 - 01/2012
1	Interleukin-13IBA 02/2022
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	HLA-G Antigens (HLA G)IBA 01/2022
1	Perindopril FDA LinkGeneric 10/2021
1	Tamoxifen FDA LinkGeneric 10/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Subunit VaccinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	AllergensIBA 01/2021
1	talimogene laherparepvecIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	transcription factor NF-AT c3IBA 10/2019
1	EnzymesIBA 01/2019
1	LigandsIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	Trastuzumab (Herceptin)FDA Link 03/2014
1	Monoclonal AntibodiesIBA 03/2014
1	QuinazolinesIBA 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 12/2013
1	Complement System Proteins (Complement)IBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2012
1	NGR peptideIBA 01/2012
1	arginyl-glycyl-aspartic acidIBA 01/2012
1	Peptide Receptors (Peptide Receptor)IBA 01/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Hormones (Hormone)IBA 07/2009

Therapy/Procedure

10	Therapeutics 02/2022 - 01/2013
7	Immunotherapy 01/2022 - 01/2010
1	Drug Therapy (Chemotherapy) 01/2022
1	Organ Transplantation 01/2019
1	Precision Medicine 03/2016